MARKET

APYX

APYX

Apyx Medical Corp
NASDAQ

Real-time Quotes | Nasdaq Last Sale

11.09
-0.03
-0.27%
After Hours: 11.09 0 0.00% 16:00 09/21 EDT
OPEN
11.17
PREV CLOSE
11.12
HIGH
11.28
LOW
11.01
VOLUME
20.28K
TURNOVER
--
52 WEEK HIGH
12.01
52 WEEK LOW
4.350
MARKET CAP
380.64M
P/E (TTM)
-21.2778
1D
5D
1M
3M
1Y
5Y
Apyx Medical Corporation to Participate in the Colliers Securities 2021 Institutional Investor Conference
CLEARWATER, Fla., September 01, 2021--Apyx Medical Corporation (NASDAQ:APYX) (the "Company"), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Renuvion® in the cosmetic surgery market and J-Plasma®...
Business Wire · 09/01 20:05
BRIEF-Apyx Medical Corporation Announces Appointment Of Wendy Levine To The Company’S Board Of Directors
reuters.com · 08/30 11:33
Apyx Medical Corporation Announces Appointment of Wendy Levine to the Company’s Board of Directors
CLEARWATER, Fla., August 30, 2021--Apyx Medical Corporation (NASDAQ:APYX) (the "Company"), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Renuvion® in the cosmetic surgery market and J-Plasma® in...
Business Wire · 08/30 11:30
OPCH, MIME, URBN and VNET among after hours movers
Gainers: OPCH +7.3%. MIME +7.1%. SCSC +6.1%. EVK +4.3%. SHCR +3.6%. Losers: URBN -5.5%. OTLY -4.1%. VNET -3.9%. APYX -3.6%. LCID -3.0%.
Seekingalpha · 08/24 21:40
Cowen And Company, Llc Buys Lowe's Inc, S&P 500 ETF TRUST ETF, The Home Depot Inc, Sells ...
GuruFocus News · 08/16 18:38
JMP Securities Maintains Market Outperform on Apyx Medical, Raises Price Target to $14
JMP Securities analyst David Turkaly maintains Apyx Medical (NASDAQ:APYX) with a Market Outperform and raises the price target from $12 to $14.
Benzinga · 08/13 12:41
--JMP Securities Adjusts Price Target on Apyx Medical to $14 From $12, Maintains Market Outperform Rating
MT Newswires · 08/13 09:43
77 Biggest Movers From Yesterday
Gainers Powerbridge Technologies Co., Ltd. (NASDAQ: PBTS) shares surged 65.4% to close at $2.10 on Thursday after the company announced it is expanding its blockchain business to engage in cryptocurrency mining.
Benzinga · 08/13 09:14
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of APYX. Analyze the recent business situations of Apyx Medical Corp through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 4 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average APYX stock price target is 14.00 with a high estimate of 15.00 and a low estimate of 13.00.
EPS
Institutional Holdings
Institutions: 115
Institutional Holdings: 21.77M
% Owned: 63.44%
Shares Outstanding: 34.32M
TypeInstitutionsShares
Increased
17
1.52M
New
14
470.89K
Decreased
26
1.36M
Sold Out
8
349.82K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
+0.10%
Healthcare Equipment & Supplies
+0.22%
Key Executives
Chairman/Independent Director
Andrew Makrides
Chief Executive Officer/Director
Charles Goodwin
Vice Chairman/Independent Director
John Andres
Chief Financial Officer/Treasurer/Secretary
Tara Semb
Executive Vice President
Todd Hornsby
Senior Vice President
Moshe Citronowicz
Lead Director/Independent Director
Lawrence Waldman
Director
Wendy Levine
Independent Director
Minnie Baylor-Henry
Independent Director
Michael Geraghty
Independent Director
Craig Swandal
No Data
About APYX
Apyx Medical Corporation, formerly Bovie Medical Corporation, is an energy-based medical device company. The Company is engaged in the design, development and manufacturing of electrosurgical equipment by producing equipment for medical device manufacturers through original equipment manufacturing (OEM) agreements, as well as start-up companies. It operates through two segments: OEM and J-Plasma. It is engaged in developing and marketing a range of electrosurgical products and technologies, as well as related medical products used in doctor's offices, surgery centers and hospitals around the world. It also develops J-Plasma, a helium-based plasma surgical product. The J-Plasma system consists of an electrosurgical generator unit, a handpiece and a supply of helium gas. Its products are marketed through brands, including Aaron, DERM, IDS and ICON, and on a private label basis to distributors around the world. It offers products in electrosurgery, cauteries and other products categories.

Webull offers kinds of Apyx Medical Corp stock information, including NASDAQ:APYX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, APYX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading APYX stock methods without spending real money on the virtual paper trading platform.